Baird Medical的微波消融系统在纽约Elk Medical获得临床采用和医疗保险报销，用于甲状腺结节治疗

Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the clinical adoption of its MWA system at Elk Medical, a prominent private endocrinology practice in Brooklyn, New York.

Dr. Kazeem, a highly experienced endocrinologist with over 30 years of clinical practice, has performed nine MWA procedures in recent months. The procedures focused on treating patients with large thyroid nodules, offering a non-surgical alternative.

The clinic reported that these initial MWA procedures have been successfully reimbursed by Medicare. This achievement represents an encouraging early step in supporting broader patient access to the Company's MWA system.

This successful reimbursement in a key U.S. market provides an early indication of the potential for clinical adoption and economic viability of MWA therapy, supporting Baird Medical's mission to broaden access to minimally invasive thyroid treatments.